- Home
- ACRE vs ORMP Comparison
ACRE vs ORMP Comparison
Compare ACRE & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACRE | ORMP |
|---|---|---|
| Founded | 2011 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.4M | 197.6M |
| IPO Year | 2011 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ACRE | ORMP |
|---|---|---|
| Price | $3.31 | $4.07 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 633.7K | 137.1K |
| Earning Date | 11-06-2026 | 11-12-2026 |
| Dividend Yield | ★ 17.39% | 6.14% |
| EPS Growth | 26.17 | ★ 412.50 |
| EPS | 1.35 | ★ 2.76 |
| Revenue | ★ $54,833,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.86 | N/A |
| P/E Ratio | $2.56 | ★ $1.47 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $3.44 | $2.09 |
| 52 Week High | $5.89 | $5.47 |
Technical Indicators
Market Signals| Indicator | ACRE | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 21.52 | 30.54 |
| Support Level | N/A | $3.91 |
| Resistance Level | $5.37 | $4.22 |
| Average True Range (ATR) | 0.14 | 0.16 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 0.68 | 18.07 |
Price Performance
Historical ComparisonAbout ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a real estate investment trust mainly engaged in originating and investing in commercial real estate (CRE) loans and related investments. It operates in one segment, namely originating and managing a diversified portfolio of CRE debt-related investments. The company recognizes the majority of its revenues in the form of interest income, which it receives from loans.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.